BioCentury
ARTICLE | Clinical News

Calmangafodipir: Completed Phase IIb enrollment

November 10, 2014 8:00 AM UTC

PledPharma completed enrollment of 126 patients in the double-blind, international Phase IIb PLIANT trial evaluating 2 and 5 umol/kg IV PledOx given 30 minutes prior to FOLFOX6 (5-FU, leucovorin and o...